CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Cyclodextrin

环糊精 杂质对照品Cyclodextrin Impurities

34 个杂质条目34 impurity entries

本页汇总 环糊精 的 34 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 34 impurity reference standards of Cyclodextrin. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 环糊精(Cyclodextrin)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesMono-(6-sulfinic acid)-Sugammadex: A newly identified cyclodextrin-based oxidative impurity in industrial production
    Carbohydrate polymers · 2025 · Rávai B et al.  ·  PMID 40409805  ·  DOI
  2. 杂质研究Impurity studiesImpurity profiling of dexamphetamine sulfate by cyclodextrin-modified microemulsion electrokinetic chromatography
    Electrophoresis · 2010 · Wongwan S, Scriba GK  ·  PMID 20690151  ·  DOI
  3. 杂质研究Impurity studiesStability characterization, kinetics and mechanism of tacrolimus degradation in cyclodextrin solutions
    International journal of pharmaceutics · 2020 · Prajapati M et al.  ·  PMID 32599134  ·  DOI

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法SynthesisSynthesis of cyclodextrin-based polyrotaxanes and polycatenanes for supramolecular pharmaceutical sciences
    Carbohydrate polymers · 2024 · Higashi T et al.  ·  PMID 38710552  ·  DOI
  • 合成方法SynthesisUltrafast Synthesis of Graphene-Embedded Cyclodextrin-Metal-Organic Framework for Supramolecular Selective Absorbency and Supercapacitor Performance
    Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023 · Zhang W et al.  ·  PMID 37635132  ·  DOI

环糊精 —— 原料药与杂质对照品Cyclodextrin — drug substance & impurities

共 34 个条目(含原料药本体)34 items incl. the drug substance
α-Cyclodextrin structure
—
α-环糊精α-Cyclodextrin
α-Cyclodextrin
CAS No.10016-20-3
Chemical FormulaC36H60O30
Purity>95%询价On request
10mg25mg50mg100mg
Eicosaacetylmaltohexaose structure
—
二十乙酰基麦芽六糖Eicosaacetylmaltohexaose
Eicosaacetylmaltohexaose
CAS No.102671-24-9
Chemical FormulaC76H102O51
Purity>95%询价On request
10mg25mg50mg100mg
Maltoheptaose Tricosaacetate structure
—
二十三乙酰基麦芽七糖Maltoheptaose Tricosaacetate
Maltoheptaose Tricosaacetate
CAS No.114715-54-7
Chemical FormulaC88H118O59
Purity>95%询价On request
10mg25mg50mg100mg
6-Monodeoxy-6-monoamino-β-cyclodextrin Hydrochloride structure
—
6-单脱氧-6-单氨基-β-环糊精盐酸盐6-Monodeoxy-6-monoamino-β-cyclodextrin Hydrochloride
6-Monodeoxy-6-monoamino-β-cyclodextrin Hydrochloride
CAS No.126927-47-7
Chemical FormulaC42H71NO34·HCl
Purity>95%询价On request
10mg25mg50mg100mg
(2-Hydroxypropyl)-α-cyclodextrin (DS~4.5) structure
—
(2-羟丙基)-α-环糊精 (DS~4.5)(2-Hydroxypropyl)-α-cyclodextrin (DS~4.5)
(2-Hydroxypropyl)-α-cyclodextrin (DS~4.5)
CAS No.128446-33-3
Chemical FormulaC36H60-nO30·n(C3H7O)
Purity>95%询价On request
10mg25mg50mg100mg
(2-Hydroxypropyl)-γ-cyclodextrin structure
—
(2-羟丙基)-γ-环糊精(2-Hydroxypropyl)-γ-cyclodextrin
(2-Hydroxypropyl)-γ-cyclodextrin
CAS No.128446-34-4
Chemical FormulaC48H80-nO40·n(C3H7O)
Purity>95%询价On request
10mg25mg50mg100mg
(2-Hydroxypropyl)-β-cyclodextrin (DS~4.5) structure
—
(2-羟丙基)-β-环糊精 (DS~4.5)(2-Hydroxypropyl)-β-cyclodextrin (DS~4.5)
(2-Hydroxypropyl)-β-cyclodextrin (DS~4.5)
CAS No.128446-35-5
Chemical FormulaC42H70-nO35·n(C3H7O)
Purity>95%询价On request
10mg25mg50mg100mg
Methyl-beta-cyclodextrin (DS~12) structure
—
甲基β-环糊精(DS~12)Methyl-beta-cyclodextrin (DS~12)
Methyl-beta-cyclodextrin (DS~12)
CAS No.128446-36-6
Chemical FormulaC42H70-nO35·(CH3)n
Purity>95%询价On request
10mg25mg50mg100mg
Hexacosaacetyl Maltooctaocse structure
—
二十六乙酰基麦芽八糖Hexacosaacetyl Maltooctaocse
Hexacosaacetyl Maltooctaocse
CAS No.132830-86-5
Chemical FormulaC100H134O67
Purity>95%询价On request
10mg25mg50mg100mg
Cyclodecaamylose structure
—
环十葡聚糖Cyclodecaamylose
Cyclodecaamylose
CAS No.156510-98-4
Chemical FormulaC60H100O50
Purity>95%询价On request
10mg25mg50mg100mg
6A-O-(2-Hydroxypropyl)-β-cyclodextrin structure
—
6A-O-(2-羟丙基)-β-环糊精6A-O-(2-Hydroxypropyl)-β-cyclodextrin
6A-O-(2-Hydroxypropyl)-β-cyclodextrin
CAS No.177317-02-1
Chemical FormulaC45H76O36
Purity>95%询价On request
10mg25mg50mg100mg
Sulfobutylated β-Cyclodextrin Sodium Salt (DS~4) structure
—
磺基丁基β-环糊精钠盐 (DS~4)Sulfobutylated β-Cyclodextrin Sodium Salt (DS~4)
Sulfobutylated β-Cyclodextrin Sodium Salt (DS~4)
CAS No.182410-00-0
Chemical FormulaC42H70O35·n(C4H8-1NaO3S)
Purity>95%询价On request
10mg25mg50mg100mg
Heptakis(2,3-di-O-acetyl-6-sulfo)-beta-cyclodextrin sodium salt structure
—
庚烷(2,3-二-O-乙酰基-6-磺基)-β-环糊精钠盐Heptakis(2,3-di-O-acetyl-6-sulfo)-beta-cyclodextrin sodium salt
Heptakis(2,3-di-O-acetyl-6-sulfo)-beta-cyclodextrin sodium salt
CAS No.196398-66-0
Chemical FormulaC70H91O70S7Na7
Purity>95%询价On request
10mg25mg50mg100mg
Heptakis(6-sulfo)-beta-cyclodextrin sodium salt structure
—
庚烷(6-磺基)-β-环糊精钠盐Heptakis(6-sulfo)-beta-cyclodextrin sodium salt
Heptakis(6-sulfo)-beta-cyclodextrin sodium salt
CAS No.197587-31-8
Chemical FormulaC42H63O56S7Na7
Purity>95%询价On request
10mg25mg50mg100mg
Alpha-cyclodextrin phosphate sodium salt (DS~2-6) structure
—
α-环糊精磷酸钠盐(DS~2-6)Alpha-cyclodextrin phosphate sodium salt (DS~2-6)
Alpha-cyclodextrin phosphate sodium salt (DS~2-6)
CAS No.199684-60-1
Chemical FormulaC36H60-nO30·n(NaHPO3)
Purity>95%询价On request
10mg25mg50mg100mg
Beta-cyclodextrin phosphate sodium salt (DS~2-6) structure
—
β-环糊精磷酸钠盐(DS~2-6)Beta-cyclodextrin phosphate sodium salt (DS~2-6)
Beta-cyclodextrin phosphate sodium salt (DS~2-6)
CAS No.199684-61-2
Chemical FormulaC42H70-nO35·n(PO3HNa)
Purity>95%询价On request
10mg25mg50mg100mg
Gamma-cyclodextrin phosphate sodium salt (DS~2-6) structure
—
γ-环糊精磷酸钠盐(DS~2-6)Gamma-cyclodextrin phosphate sodium salt (DS~2-6)
Gamma-cyclodextrin phosphate sodium salt (DS~2-6)
CAS No.199684-62-3
Chemical FormulaC48H80-nO40·n(PO3HNa)
Purity>95%询价On request
10mg25mg50mg100mg
Heptakis(2,3-di-O-methyl-6-sulfo)-beta-cyclodextrin sodium salt structure
—
庚烷(2,3-二-O-甲基-6-磺基)-β-环糊精钠盐Heptakis(2,3-di-O-methyl-6-sulfo)-beta-cyclodextrin sodium salt
Heptakis(2,3-di-O-methyl-6-sulfo)-beta-cyclodextrin sodium salt
CAS No.201346-23-8
Chemical FormulaC56H91O56S7Na7
Purity>95%询价On request
10mg25mg50mg100mg
Heptakis(2,3,6-tri-O-benzoyl)-beta-cyclodextrin structure
—
庚烷(2,3,6-三邻苯甲酰基)-β-环糊精Heptakis(2,3,6-tri-O-benzoyl)-beta-cyclodextrin
Heptakis(2,3,6-tri-O-benzoyl)-beta-cyclodextrin
CAS No.23666-43-5
Chemical FormulaC189H154O56
Purity>95%询价On request
10mg25mg50mg100mg
6-Monodeoxy-6-monoamino-β-cyclodextrin structure
—
6-单脱氧-6-单氨基-β-环糊精6-Monodeoxy-6-monoamino-β-cyclodextrin
6-Monodeoxy-6-monoamino-β-cyclodextrin
CAS No.29390-67-8
Chemical FormulaC42H71NO34
Purity>95%询价On request
10mg25mg50mg100mg
6-deoxy-6-amino-α-cyclodextrin structure
—
6-脱氧-6-氨基-α-环糊精6-deoxy-6-amino-α-cyclodextrin
6-deoxy-6-amino-α-cyclodextrin
CAS No.29556-37-4
Chemical FormulaC36H61NO29
Purity>95%询价On request
10mg25mg50mg100mg
Heptakis(6-deoxy-6-iodo)-beta-cyclodextrin structure
—
庚烷(6-脱氧-6-碘)-β-环糊精Heptakis(6-deoxy-6-iodo)-beta-cyclodextrin
Heptakis(6-deoxy-6-iodo)-beta-cyclodextrin
CAS No.30754-23-5
Chemical FormulaC42H63O28I7
Purity>95%询价On request
10mg25mg50mg100mg
Heptakis(6-amino-6-deoxy)-β-cyclodextrin structure
—
七(6-氨基-6-去氧)-β-环糊精Heptakis(6-amino-6-deoxy)-β-cyclodextrin
Heptakis(6-amino-6-deoxy)-β-cyclodextrin
CAS No.30754-24-6
Chemical FormulaC42H77N7O28
Purity>95%询价On request
10mg25mg50mg100mg
Maltohexaose structure
—
麦芽六糖Maltohexaose
Maltohexaose
CAS No.34620-77-4
Chemical FormulaC36H62O31
Purity>95%询价On request
10mg25mg50mg100mg
Maltoheptaose structure
—
麦芽七糖Maltoheptaose
Maltoheptaose
CAS No.34620-78-5
Chemical FormulaC42H72O36
Purity>95%询价On request
10mg25mg50mg100mg
Beta-cyclodextrin sulfate sodium salt (DS~13) structure
—
β-环糊精硫酸钠(DS~13)Beta-cyclodextrin sulfate sodium salt (DS~13)
Beta-cyclodextrin sulfate sodium salt (DS~13)
CAS No.37191-69-8
Chemical FormulaC42H70-nO35·n(SO3Na)
Purity>95%询价On request
10mg25mg50mg100mg
Heptakis(2,3,6-tri-O-methyl)-beta-cyclodextrin structure
—
庚烷(2,3,6-三-O-甲基)-β-环糊精Heptakis(2,3,6-tri-O-methyl)-beta-cyclodextrin
Heptakis(2,3,6-tri-O-methyl)-beta-cyclodextrin
CAS No.55216-11-0
Chemical FormulaC63H112O35
Purity>95%询价On request
10mg25mg50mg100mg
Heptakis(6-amino-6-deoxy)-β-cyclodextrin Heptahydrochloride structure
—
七(6-氨基-6-去氧)-β-环糊精七盐酸盐Heptakis(6-amino-6-deoxy)-β-cyclodextrin Heptahydrochloride
Heptakis(6-amino-6-deoxy)-β-cyclodextrin Heptahydrochloride
CAS No.65024-90-0
Chemical FormulaC42H77N7O28·7HCl
Purity>95%询价On request
10mg25mg50mg100mg
Maltooctaose structure
—
麦芽八糖Maltooctaose
Maltooctaose
CAS No.66567-45-1
Chemical FormulaC48H82O41
Purity>95%询价On request
10mg25mg50mg100mg
6-Mono-O-(p-toluenesulfonyl)-beta-cyclodextrin structure
—
6-单-O-(对甲苯磺酰基)-β-环糊精6-Mono-O-(p-toluenesulfonyl)-beta-cyclodextrin
6-Mono-O-(p-toluenesulfonyl)-beta-cyclodextrin
CAS No.67217-55-4
Chemical FormulaC49H76O37S
Purity>95%询价On request
10mg25mg50mg100mg
Alpha-cyclodextrin sulfate sodium salt (DS~12) structure
—
α-环糊精硫酸钠(DS~12)Alpha-cyclodextrin sulfate sodium salt (DS~12)
Alpha-cyclodextrin sulfate sodium salt (DS~12)
CAS No.699020-02-5
Chemical FormulaC36H60-nO30·n(SO3Na)
Purity>95%询价On request
10mg25mg50mg100mg
β-Cyclodextrin structure
—
β-环糊精β-Cyclodextrin
β-Cyclodextrin
CAS No.7585-39-9
Chemical FormulaC42H70O35
Purity>95%询价On request
10mg25mg50mg100mg
δ-Cyclodextrin structure
—
δ-环糊精δ-Cyclodextrin
δ-Cyclodextrin
CAS No.85220-53-7
Chemical FormulaC54H90O45
Purity>95%询价On request
10mg25mg50mg100mg
6-Monodeoxy-6-monoazido-beta-cyclodextrin structure
—
6-单脱氧-6-单叠氮-β-环糊精6-Monodeoxy-6-monoazido-beta-cyclodextrin
6-Monodeoxy-6-monoazido-beta-cyclodextrin
CAS No.98169-85-8
Chemical FormulaC42H69O34N3
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

环糊精 —— 研究文献与合成路线Cyclodextrin — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 环糊精 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Cyclodextrin. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Mono-(6-sulfinic acid)-Sugammadex: A newly identified cyclodextrin-based oxidative impurity in industrial production
    Rávai B, Kese I, Szakály PS, et al. · Carbohydrate polymers · 2025 · 被引 1cited 1
  2. An Archaeal Cyclodextrin Glycosyltransferase from Haloferax sp.: Characterization and Application in Starch Degradation
    Li Y, Li A, Long X, et al. · International journal of molecular sciences · 2026
  3. Mitigating chemical degradation in amorphous and lipid-based formulations through cyclodextrin complexation and nanosizing
    Lee S, Pandey P · Drug development and industrial pharmacy · 2026
  4. An Archaeal Cyclodextrin Glycosyltransferase from <i>Haloferax</i> sp.: Characterization and Application in Starch Degradation
    Li Y, Li A, Long X, et al. · International journal of molecular sciences · 2026
  5. β-cyclodextrin mediated purification of sulforaphane: Selective separation of a critical impurity—5-vinyloxazolidine-2-thione
    Tian M, Gao H, Yu P, et al. · Journal of food composition and analysis : an official publication of the United Nations University, International Network of Food Data Systems · 2025
  6. Controlled Regulation of Antibacterial and Degradable Performance via Host (Cyclodextrin)-Guest (Vanillin) Multilevel Structures
    Li J, Cheng X, Wang R, et al. · ACS macro letters · 2025

合成与制备工艺专利Synthesis & process patents

  1. Process for preparing cyclodextrin
    ZHENGBIAO GU, LI CHENG, YAN HONG, ZHONGCHAO YANG · 公开号 CN101319243CN101319243 · 2008
  2. Process to produce a diclofenac cyclodextrin conjugate
    ALBUQUERQUE ROCHA GONSALVES ANTONIO MANUEL, DE BAPTISTA VEIGA FRANCISCO JOSE, SERRA ARMENIO COIMBRA, FERNANDES SOARES VIEIRA AMELIA CATARINA, et al. · 公开号 EP2422818EP2422818 · 2012
  3. Process for Preparing an Alpha-Lipoic Acid/Cyclodextrin Complex and Product Prepared
    REUSCHER HELMUT, BAUER MARK · 公开号 US2010210716US2010210716 · 2010
  4. Ferulaic acid cyclodextrin or cyclodextrin derivate inclusion compound and preparation method
    JING WANG, BAOGUO SUN, YANPING CAO, CHENGTAO WANG · 公开号 CN101485447CN101485447 · 2009
  5. Garlic oil cyclodextrin or cyclodextrin derivate inclusion compound and preparation method
    JING WANG, YANPING CAO, BAOGUO SUN, CHENGTAO WANG · 公开号 CN101485446CN101485446 · 2009

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

环糊精 杂质谱研究要点Cyclodextrin — impurity profiling notes

下面这些是拿到 环糊精 的 34 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 34 impurity entries for Cyclodextrin, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances